NHS Evidence - Neurological conditions - Pharmacologic treatment of depression in multiple sclerosis
Links shared publicly online about this topic.
- 472total visits
NHS Evidence - Neurological conditions - Pharmacologic treatment of depression in multiple sclerosis
Background Depression is a common problem in patients with multiple sclerosis (MS). It is unclear which pharmacologic treatment is the most effective and the least harmful. Objectives To investigate the efficacy and tolerability of pharmacologic treatments for depression in patients with MS. Search strategy We searched the Cochrane Multiple Sclerosis Group's Trials Register (June 2010), reference lists of relevant articles and conference proceedings. Regulatory agencies were used as additional s
View full resource at library.nhs.uk
Tags: Neurology, Multiple Sclerosis, Depression
Most Recently Shared on March 1, 2011 at 4:26 am By:
Pharmacologic treatment of depression in multiple sclerosis: Objectives: To investigate the efficacy and tolerab... http://bit.ly/fCZR1e
Advertisement
